FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa
HOUSTON, Sept. 30, 2024 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued […]
Crown Provides Fourth Quarter and Full Year 2024 Revenue Guidance, Narrowing Gap to Profitability
– Fourth Quarter 2024 Revenue Estimated $9 Million – Full Year 2024 Revenue Estimated $22 Million LOS ANGELES, Sept. 30, […]
SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment
FDA confirms that SciSparc’s study may proceed only a month after application submission TEL AVIV, Israel, Sept. 30, 2024 (GLOBE […]
Highwoods Reports No Notable Damage from Hurricane Helene
RALEIGH, N.C., Sept. 30, 2024 (GLOBE NEWSWIRE) — Highwoods Properties, Inc. (NYSE:HIW) reports after having conducted a thorough assessment of […]
Cytokinetics Presents Additional Data From SEQUOIA-HCM at the HFSA Annual Scientific Meeting
Responder Analyses Show Treatment with Aficamten Demonstrated Improvementson Multiple Assessments of Clinical Significance to Cardiologists Results Simultaneously Published inthe Journal […]
Silynxcom Announces $740,000 in Orders for Tactical Communication Equipment from The Israel Defense Forces
Silynxcom has received a total of approximately $1,550,000 in orders from the Israel Defense Forces since the beginning of the […]
Hepsiburada Announces the Second Issuance of Asset-backed Securities
ISTANBUL, Sept. 30, 2024 (GLOBE NEWSWIRE) — D-MARKET Electronic Services & Trading (d/b/a “Hepsiburada”) (NASDAQ: HEPS), a leading Turkish e-commerce […]
SLR Investment Corp. Announces Acquisition of Factoring Business
NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) — SLR Investment Corp. (NASDAQ: SLRC) (the “Company” or “SLRC”) today announced that on […]
MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS)
LA JOLLA, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market […]
Pretzelmaker Adds a Bucket List Worthy Menu Item – Bucket of Bites!
The Innovator of Pretzel Bites Launches Bucket of Bites to Elevate Snack Game LOS ANGELES, Sept. 30, 2024 (GLOBE NEWSWIRE) […]
